Pyronaridine-artesunate retreatment for malaria

Lancet Infect Dis. 2016 Feb;16(2):136-7. doi: 10.1016/S1473-3099(15)00353-9. Epub 2015 Oct 23.

Authors

Sabine Bélard¹, Florian Kurth²

Affiliations

¹ Department of Pediatric Pneumology and Immunology, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: sabine.belard@charite.de.
² Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie, Charité -Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.

PMID: 26601737
DOI: 10.1016/S1473-3099(15)00353-9

No abstract available

Publication types

Comment

MeSH terms

Antimalarials / administration & dosage*
Antimalarials / adverse effects*
Artemisinins / therapeutic use*
Female
Humans
Malaria / drug therapy*
Male
Naphthyridines / administration & dosage*
Plasmodium / drug effects*

Substances

Antimalarials
Artemisinins
Naphthyridines